Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
about
The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?Ethical aspects of registry-based research in the Nordic countriesTiming of therapies for Down syndrome: the sooner, the betterUse of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and SwedenSpecific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.Clinical epidemiology in the era of big data: new opportunities, familiar challenges.Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial.Effects of Fluoxetine on Human Embryo Development.Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey.Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative dataSelective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.Cardiac dysfunction and prenatal exposure to venlafaxine.Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.Use of selective serotonin-reuptake inhibitors in the first trimester and risk of cardiovascular-related malformations: a meta-analysis of cohort studies.Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes: the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy.First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.Gastroschisis in Europe - A Case-malformed-Control Study of Medication and Maternal Illness during Pregnancy as Risk Factors.The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies.The risks associated with prenatal antidepressant exposure: time for a precision medicine approach.Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies.Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making.Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies.Selective serotonin reuptake inhibitors and risk of major congenital anomalies for pregnancies in Japan: A nationwide birth cohort study of the Japan Environment and Children's Study.Selective Serotonin Reuptake Inhibitors as First-Line Antidepressant Therapy for Perinatal Depression.Registers of the Swedish total population and their use in medical research.Prenatal exposure to antidepressants and risk of epilepsy in childhood.Meta-analysis requires independent observations and freedom from bias.Most Frequently Reported Prescription Medications and Supplements in Couples Planning Pregnancy: The LIFE Study.Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium.Pharmacological Management of Bipolar Disorder in Pregnancy.Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression.Case-control studies require appropriate population controls: an example of error in the SSRI birth defect literature.In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat.Effect of maternal fluoxetine exposure on lung, heart, and kidney development in rat neonates.Maternal drug use and the risk of anorectal malformations: systematic review and meta-analysis.MAGDALENA: study protocol of a randomised, placebo-controlled trial on cognitive development at 2 years of age in children exposed to SSRI in uteroSelective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births
P2860
Q26741187-1D1C268E-59E1-4988-9C62-BF4B0DE6595AQ26773188-0814AD24-F311-4053-A691-BD00B4CA759BQ26779297-44128A17-A8FB-47CA-9DB9-D1CB206943F9Q28551620-96D4DBAD-60FE-4B4E-8780-66BBB6F553B8Q30979346-80177554-234B-496F-BF79-EB9564C93193Q33627674-01117FDD-9119-4C0C-AD71-21C94A9E8E7AQ34483257-1F5AD586-71CA-44C9-9214-E377FEFCB3EEQ35963421-3CCB0141-E7D4-42EA-8BD0-15902D801150Q36068009-CCB813B2-F0CB-4328-A951-868CFCF08577Q36105381-7859015F-3DF4-4FF8-BD54-3D71DFF6A0ADQ36207250-D49F04C6-B7CF-43B6-A0A2-E122EACF5B4DQ36209588-8D1D868F-887F-4C47-8D6C-6F0F08E0829AQ36706789-E97E6E72-D29E-456E-87BE-8115CEA5539AQ36797574-E9A486F1-9D6E-4E7B-9603-6023E23BAFE7Q37612128-BFC16F2C-F1FD-4AAC-B903-72E16D14298BQ37654878-693C428D-B639-4A59-8AD7-BECAFDAC2AB1Q38407850-F8F4488D-7C29-4F19-918F-4FCCD8CB613DQ38599005-4BDEBC0A-5FB1-4CD4-9CA3-65BA1A9B5A04Q38608049-4173F4E5-B15E-41DD-8930-1C7F37341F6FQ38672603-28F0A802-050A-4721-9151-2117854661E7Q38722632-0D91E1CD-B61F-4CFE-9E43-BC1554BD96AFQ38781285-2A2D2ACD-9E22-4FB7-B9B3-0A949297C6DFQ38811512-F962B5FA-33EB-46F4-A407-D4CD814501B4Q38988107-9A7CD0CF-EECD-49B0-85AF-CD778C73A596Q39160045-F5CC821B-9EC0-46C7-8F8C-CD248F3C4146Q39293315-ED9E11F3-70DC-4E33-94D1-3A4AEE116286Q40105921-97E12112-19F6-418A-B856-4CE69AF2DD81Q40498883-060A1CD5-BD12-4F5B-B4E5-9D4371ED95BCQ42770388-9F765EED-F4D3-4E13-8EA6-35C457971B36Q44319492-CC60A390-8D88-4548-B4E6-025F5535B682Q47313347-3108EEF1-58AC-43C7-996A-145C1227F365Q47652163-327FEEA6-F2C1-40A8-AF89-53EEA15D991AQ48062592-009FFE9C-FF6D-4803-8093-A56AFB05EF23Q48071545-718B4447-2000-44B1-AC7E-2CF9851A8E2DQ50879823-858E1BDA-FA9B-4BF7-87BD-222DD305001AQ55005697-1637A195-2C92-4923-9240-EAE20EDA8B0DQ55313592-ECE050AE-BC82-4DF0-A6D4-D72CF96A7FA2Q58800251-1AB3B2B1-85E1-491A-8E53-BFF41489743AQ59129888-3A4601D4-BF8E-4522-966E-D8C9525E9D9F
P2860
Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Selective serotonin reuptake i ...... hort study and sibling design.
@ast
Selective serotonin reuptake i ...... hort study and sibling design.
@en
type
label
Selective serotonin reuptake i ...... hort study and sibling design.
@ast
Selective serotonin reuptake i ...... hort study and sibling design.
@en
prefLabel
Selective serotonin reuptake i ...... hort study and sibling design.
@ast
Selective serotonin reuptake i ...... hort study and sibling design.
@en
P2093
P2860
P50
P356
P1433
P1476
Selective serotonin reuptake i ...... hort study and sibling design.
@en
P2093
Anders Engeland
Bengt Haglund
Helga Zoega
Helle Kieler
Mette Nørgaard
Miia Artama
Randi Selmer
P2860
P356
10.1136/BMJ.H1798
P407
P577
2015-04-17T00:00:00Z